Immediate Management: IV Ceftriaxone with Temporary Pacing
This patient requires IV ceftriaxone 2g daily for 14-21 days with temporary transvenous pacing (Option C). This is Lyme carditis with third-degree AV block requiring hospitalization and continuous monitoring.
Clinical Reasoning
This presentation is classic for Lyme carditis:
- Recent camping in Virginia (endemic area)
- Constitutional symptoms (fever, myalgia, fatigue) 3 weeks ago
- Progressive cardiac conduction disease (third-degree AV block, HR 35-52 bpm)
- Lightheadedness and diaphoresis (symptoms of bradycardia)
- Acute facial nerve palsy (right-sided Bell's palsy)
- No alternative explanation (normal troponin, no endocarditis, negative stroke workup)
Why IV Antibiotics Over Oral
The 2020 IDSA/AAN/ACR guidelines recommend hospitalized patients with Lyme carditis receive IV ceftriaxone initially until clinical improvement, then switch to oral antibiotics to complete 14-21 days total treatment 1. While outpatients with Lyme carditis can receive oral therapy, this patient requires hospitalization due to:
- Third-degree AV block (complete heart block)
- Symptomatic bradycardia (lightheadedness, diaphoresis)
- Heart rate 35-52 bpm requiring continuous monitoring
The guidelines specifically state hospitalized patients should receive IV ceftriaxone initially over oral antibiotics 1. Once the AV block improves and the patient is clinically stable, you can transition to oral doxycycline to complete the 14-21 day course.
Why Temporary Pacing, Not Permanent
For symptomatic bradycardia due to Lyme carditis that cannot be managed medically, the guidelines strongly recommend temporary pacing modalities rather than implanting a permanent pacemaker 1. This is critical because:
- Lyme carditis-associated AV block is reversible with antibiotic treatment
- Most patients recover normal conduction within 1-6 weeks
- Permanent pacemaker implantation would be unnecessary and expose the patient to device-related complications
- The ESC guidelines confirm permanent pacing is not indicated when AV block is due to reversible causes 2
Why Not the Other Options
Option A (Oral doxycycline with temporary pacing): While oral doxycycline is appropriate for outpatient Lyme carditis, this hospitalized patient with third-degree AV block and symptomatic bradycardia should receive IV ceftriaxone initially per guidelines 1.
Option B (IV ceftriaxone and dobutamine with cardiac catheterization): This treats acute coronary syndrome, which is ruled out by normal troponin, normal echo with EF 55%, and the clinical picture of Lyme carditis. Dobutamine and catheterization are inappropriate here.
Option D (IV ceftriaxone with permanent pacemaker): The permanent pacemaker is the critical error. Lyme carditis causes reversible conduction disease that resolves with antibiotics 1. Permanent pacing would be premature and inappropriate.
Treatment Duration and Monitoring
- Total antibiotic duration: 14-21 days 1
- Start IV ceftriaxone 2g daily
- Continuous cardiac monitoring is mandatory for patients with significant PR prolongation, arrhythmias, or clinical manifestations of myopericarditis 1
- Temporary pacing (transvenous or transcutaneous) only if symptomatic bradycardia cannot be managed medically
- Once AV conduction improves and patient is stable, transition to oral doxycycline to complete therapy
- Most patients show improvement within days to weeks of antibiotic initiation
Common Pitfalls to Avoid
- Do not implant a permanent pacemaker in acute Lyme carditis—the conduction disease is reversible
- Do not delay antibiotics while waiting for Lyme serology results; treat empirically given the high clinical suspicion
- Do not discharge patients with third-degree AV block or symptomatic bradycardia—they require continuous monitoring
- The facial palsy confirms neurologic involvement but does not change the cardiac management approach